VoterlyH.R. 4764: TRANSPLANT Act of 2020
116th Congress · Sponsored from California · In progress
What this bill does
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020 This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells. In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.
Key facts
- Status In progress
- Introduced 2019-10-18
- Policy area Health
- Cosponsors 52
- Latest action Message on Senate action sent to the House.
Sponsor
Who funds the sponsor?
Rep. Matsui, Doris O. [D-CA-6] introduced H.R. 4764. On Voterly you can see their top campaign donors from public Federal Election Commission records — individuals, PACs, and industry groups (follow the money) — and compare that with how they vote.
See Rep. Matsui, Doris O. [D-CA-6]'s donors & voting record →
Campaign donations show who helps fund the sponsor's election; they are not the same as who drafted or lobbied for the bill text. Lobbying disclosures are separate public records.
Take a position & compare alignment
Agree or disagree with H.R. 4764? Go to the homepage to record your view and compare your stance with how your representatives vote. See Rep. Matsui, Doris O. [D-CA-6]'s profile to vote on their bills and check your alignment % with the sponsor.
Read the official text on Congress.gov →
Frequently asked questions
What does H.R. 4764 do?
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020 This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a po…
Who sponsored H.R. 4764?
Rep. Matsui, Doris O. [D-CA-6] (D) of California is the lead sponsor.
How do I find out who funds or lobbies for H.R. 4764?
Campaign-finance records (Federal Election Commission) show who funds the bill's sponsor. Separately, federal lobbying disclosures filed under the Lobbying Disclosure Act list the companies and lobbyists who reported lobbying on specific bills. Voterly links the sponsor's donors; lobbying records are public at the U.S. Senate and House lobbying databases.
Is H.R. 4764 now law?
Not yet. The current status is "In progress." See the latest action above for details.